|
|
| Line 19: |
Line 19: |
|
| |
|
| </StructureSection> | | </StructureSection> |
| ==3D structures of fibroblast growth factor receptor==
| |
|
| |
|
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| |
| {{#tree:id=OrganizedByTopic|openlevels=0|
| |
|
| |
| *FGFR1
| |
|
| |
| *''FGFR1 tyrosine kinase domain residues 458-765''
| |
|
| |
| **[[4uwy]], [[6mzq]] – hFGFR1 TKD - human<br />
| |
| **[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br />
| |
| **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a], [[6mzw]], [[6c1o]] – hFGFR1 TKD + inhibitor <br />
| |
| **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]], [[6p68]], [[6p69]], [[6c18]], [[6c19]], [[6c1b]], [[6c1c]], [[5z0s]] – hFGFR1 TKD (mutant) + inhibitor <br />
| |
| **[[5zv2]] – hFGFR1 TKD (mutant) + anti-cancer drug<br />
| |
| **[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br />
| |
| **[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br />
| |
| **[[3gqi]] – hFGFR1 TKD (mutant) with PTR + ACP <br />
| |
| **[[3gql]] – hFGFR1 TKD (mutant) + substrate <br />
| |
|
| |
| *''FGFR1 ligand-binding domain D1 residues 35-208''
| |
|
| |
| **[[2cr3]] – hFGFR1 LBD D1 - NMR<br />
| |
| **[[2ckn]] – FGFR1 LBD D1 – mouse - NMR<br />
| |
|
| |
| *''FGFR1 D1 complex with FGF''
| |
|
| |
| **[[5w59]] – hFGFR1 LBD D1 + FGF9<br />
| |
|
| |
| *''FGFR1 D2,D3 residues 142-365 complex with FGF''
| |
|
| |
| **[[3ojv]] – hFGFR1 LBD D2,D3 (mutant) + hFGF1 - human <br />
| |
| **[[1cvs]] – hFGFR1 LBD D2,D3 (mutant) + hFGF2 (mutant) <br />
| |
| **[[1evt]] – hFGFR1 LBD D2,D3 + hFGF1 <br />
| |
| **[[1fq9]] – hFGFR1 (mutant) LBD D2,D3 + hFGF2 (mutant) + HS<br />
| |
| **[[5w21]] – hFGFR1 LBD D2,D3 + hFGF23 + klotho <br />
| |
|
| |
| *FGFR2
| |
|
| |
| *''FGFR2 tyrosine kinase domain''
| |
|
| |
| **[[1gjo]], [[1oec]], [[2psq]] – hFGFR2 TKD <br />
| |
| **[[2pvy]], [[2pwl]], [[2py3]], [[2pz5]], [[2pzp]], [[2pzr]], [[2q0b]], [[4j95]], [[4j96]], [[4j97]], [[4j98]], [[4j99]], [[5ugx]], [[5uhn]], [[5ui0]] – hFGFR2 TKD (mutant) + ACP<br />
| |
| **[[5ugl]] – hFGFR2 TKD (mutant) + ANP<br />
| |
| **[[3b2t]] – hFGFR2 TKD (mutant) + adenosine derivative<br />
| |
| **[[2pvf]] – hFGFR2 TKD with PTR + ACP + substrate peptide<br />
| |
| **[[3cly]] – hFGFR2 TKD (mutant) with PTR + ACP <br />
| |
| **[[5eg3]] – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ<br />
| |
| **[[3ri1]] – hFGFR2 TKD + inhibitor<br />
| |
|
| |
| *''FGFR2 ligand-binding domain''
| |
|
| |
| **[[3dar]], [[3caf]], [[3euu]] – hFGFR2 LBD D2 <br />
| |
| **[[1wvz]] – hFGFR2 LBD D2 - NMR<br />
| |
| **[[4wv1]] – hFGFR2 LBD D2 + antibody<br />
| |
| **[[4hwu]] – hFGFR2 LBD D1 <br />
| |
|
| |
| *''FGFR2 complex with FGF''
| |
|
| |
| **[[1e0o]] – hFGFR2 (mutant) LBD D2,D3 + hFGF1 (mutant) + HS<br />
| |
| **[[3oj2]], [[3ojm]] – hFGFR2 (mutant) LBD D2,D3 + hFGF1 <br />
| |
| **[[1djs]] – hFGFR2 LBD D2,D3 (mutant) + hFGF1 <br />
| |
| **[[1ev2]], [[1ii4]], [[1iil]] – hFGFR2 LBD D2,D3 + hFGF2 (mutant) <br />
| |
| **[[4j23]] – hFGFR2 LBD D2,D3 (mutant) + hFGF2 (mutant) + inhibitor <br />
| |
| **[[3cu1]] – hFGFR2 LBD D2 + hFGF1 <br />
| |
| **[[2fdb]] – hFGFR2 LBD D2,D3 + hFGF8b <br />
| |
| **[[1nun]] – hFGFR2 LBD D2,D3 + hFGF10 <br />
| |
|
| |
| *FGFR3
| |
|
| |
| **[[3grw]] – hFGFR3 LBD D2,D3 + antibody<br />
| |
| **[[2lzl]] – hFGFR3 residues 357-399 – NMR<br />
| |
| **[[4k33]] – hFGFR3 kinase domain (mutant)<br />
| |
|
| |
| *''FGFR3 complex with FGF''
| |
|
| |
| **[[1ry7]] – hFGFR3 LBD + hFGF1<br />
| |
|
| |
| *FGFR4
| |
|
| |
| *''FGFR4 tyrosine kinase domain''
| |
|
| |
| **[[4tye]], [[4tyg]], [[4tyi]], [[4tyj]] – hFGFR4 TKD <br />
| |
| **[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br />
| |
| **[[5jkg]], [[5nwz]], [[5nud]] – hFGFR4 TKD + inhibitor<br />
| |
| **[[6jpj]], [[5xff]], [[5xfj]] – hFGFR4 TKD (mutant) + inhibitor<br />
| |
| **[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br />
| |
|
| |
| }}
| |
| == References == | | == References == |
| <references/> | | <references/> |
| [[Category:Topic Page]] | | [[Category:Topic Page]] |